People: Denali Therapeutics Inc (DNLI.OQ)
21 Jun 2019
Mr. Ryan Watts, Ph.D. is President, Chief Executive Officer, Co-Founder, Director of Denali Therapeutics Inc. Ryan previously served as Director of the Department of Neuroscience at Genentech, where he was employed for 11 years. During his tenure there, he led the company’s entry into neuroscience, building a department and advancing multiple programs for neurological disease from discovery to clinical testing. Ryan’s own laboratory focused on drug discovery for Alzheimer’s disease and on understanding mechanisms of neurodegeneration guided by human genetics. Ryan is also a leader in the development of improved methods for delivering therapeutic antibodies across the blood-brain barrier. He obtained his B.S. from the University of Utah and his Ph.D. in biological sciences from Stanford University.
|Total Annual Compensation, USD||855,744|
|Restricted Stock Award, USD||--|
|Long-Term Incentive Plans, USD||--|
|All Other, USD||511,119|
|Fiscal Year Total, USD||1,366,860|